Aarey Drugs & Pharmaceuticals Complete Financial Statements
In FY2026, Aarey Drugs & Pharmaceuticals (AAREYDRUGS) reported revenue ₹472 Cr, net profit ₹4 Cr and EPS ₹1.39, with a net profit margin of 0.8% and ROE of 2.9%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see AAREYDRUGS screener.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
AAREYDRUGS Revenue, Net Profit & EBITDA — Year-on-Year Growth
AAREYDRUGS YoY (March 2025 vs March 2026) — revenue -2.5%, EBITDA -46.2%, expenses -1.3%. Analyse Aarey Drugs & Pharmaceuticals ownership structure to track promoter, FII and institutional holdings.
AAREYDRUGS Income Statement — Revenue, EBITDA & Net Profit
Aarey Drugs & Pharmaceuticals revenue ₹472 Cr, EBITDA ₹7 Cr, net profit ₹4 Cr, EPS ₹1.39 (2026) — net profit margin 0.8%. Also explore AAREYDRUGS share price data to track price trends across different timeframes.
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 472 | 484 | 403 | 422 | 495 | 355 | 307 | 359 | 353 | 399 | 249 | 216 |
| Expenses | 465 | 471 | 391 | 411 | 481 | 344 | 297 | 347 | 342 | 386 | 245 | 212 |
| EBITDA | 7 | 13 | 11 | 11 | 14 | 12 | 10 | 12 | 11 | 13 | 4 | 4 |
| Operating Profit Margin % | 2.00% | 1.00% | 1.00% | 2.00% | 2.00% | 1.00% | 1.00% | 2.00% | 2.00% | 2.00% | 0.00% | 1.00% |
| Depreciation | 3 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 5 | 5 | 4 | 3 | 2 | 2 | 2 | 2 | 2 | 4 | 2 | 2 |
| Profit Before Tax | 5 | 6 | 5 | 6 | 10 | 8 | 7 | 9 | 8 | 8 | 2 | 1 |
| Tax | 2 | 2 | 1 | 2 | 4 | 2 | 1 | 2 | 2 | 3 | 1 | 0 |
| Net Profit | 4 | 4 | 5 | 4 | 7 | 7 | 6 | 7 | 6 | 6 | 1 | 1 |
| Earnings Per Share (₹) | 1.39 | 1.42 | 1.84 | 1.49 | 2.72 | 2.79 | 2.48 | 2.80 | 2.64 | 3.03 | 0.77 | 0.65 |
AAREYDRUGS Balance Sheet — Assets, Liabilities & Shareholders' Equity
AAREYDRUGS total assets ₹291 Cr, total equity ₹139 Cr, total liabilities ₹ Cr (2025) — ROE 2.9%.
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 291 | 303 | 291 | 245 | 233 | 194 | 146 | 170 | 143 | 125 | 115 |
| Current Assets | 266 | 283 | 271 | 219 | 218 | 181 | 133 | 157 | 130 | 117 | 109 |
| Fixed Assets | 16 | 13 | 14 | 15 | 14 | 12 | 12 | 12 | 12 | 8 | 6 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 272 | 289 | 277 | 230 | 218 | 181 | 133 | 157 | 130 | 117 | 109 |
| LIABILITIES | |||||||||||
| Total Liabilities | |||||||||||
| Current Liabilities | 3 | 4 | 6 | 5 | 3 | 2 | 2 | 1 | 2 | 0 | 0 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 139 | 133 | 117 | 114 | 99 | 92 | 87 | 80 | 49 | 37 | 35 |
| Share Capital | 29 | 28 | 25 | 25 | 23 | 23 | 23 | 23 | 18 | 17 | 17 |
| Reserves & Surplus | 105 | 100 | 87 | 86 | 73 | 67 | 61 | 55 | 30 | 20 | 19 |
AAREYDRUGS Cash Flow Statement — Operating, Investing & Financing
Aarey Drugs & Pharmaceuticals operating cash flow ₹10 Cr, investing ₹-6 Cr, financing ₹-5 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 10 | -3 | -1 | 1 | 6 | 3 | 1 | -20 | 1 | 6 | 3 |
| Investing Activities | -6 | -2 | 0 | -3 | -3 | -1 | -1 | -1 | -5 | -3 | -2 |
| Financing Activities | -5 | 6 | 1 | 2 | -3 | -2 | -3 | 23 | 4 | -2 | -2 |
| Net Cash Flow | 0 | 1 | 1 | -1 | 0 | 0 | -3 | 2 | -1 | 2 | -1 |